Related Experiment Video
Updated: Jul 5, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
[Influence of packed red cell transfusions on blood selenium concentration in pediatric hemato-oncology]
J Mackenroth1, K Hölig, E Kuhlisch
1Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden.
Insights
Red cell transfusions (RCT) can help correct selenium (Se) deficiency in pediatric cancer patients. While not statistically significant, Se levels increased post-transfusion, improving deficiency in some children.
Area of Science:
- Biochemistry and Nutritional Science
- Pediatric Hematology-Oncology
- Clinical Pathology
Context:
- Selenium (Se) is crucial for antioxidant pathways, with 10% of body content in human blood.
- Parents often inquire about Se supplementation for children undergoing cancer treatment.
- Concerns exist regarding potential selenium toxicity in pediatric patients.
Purpose:
- To investigate if packed red cell transfusions (RCT) contribute to selenium (Se) supply in pediatric patients with hemato-oncological diseases.
- To determine Se concentrations in patients' blood before and after RCT.
- To assess the impact of RCT on correcting Se deficiency in this vulnerable population.
Summary:
- Seventy-seven percent of transfusion units contained Se within the normal adult range.
- Patients' blood Se concentrations showed a non-significant increase post-RCT (66.2 to 70.7 microg/l).
- Se deficiency, present in 45% of patients pre-RCT, decreased to 26% post-RCT, with correction in 4/8 patients.
Impact:
- Red cell transfusions can partially correct selenium deficiency in pediatric cancer patients.
- Highlights the importance of regular Se monitoring before considering supplementation due to fluctuating levels.
- Informs clinical decisions regarding complementary therapies and nutritional support in pediatric oncology.
Background:
In humans approx. 10% of the total body selenium (Se) content is present in the blood being evenly distributed among plasma and red cells. The important role of Se in antioxidative biological pathways is proven. Many parents of children with malignancies ask for supplementation with Se as part of complementary therapy during or after the oncological treatment. However, toxic Se concentrations may easily be reached in children. In order to analyse whether Se is also supplied by red cell transfusions (RCT), we determined Se concentration in whole blood prior and after packed RCT in pediatric patients with hemato-oncological diseases.
Patients And Methods:
EDTA-blood was collected from 17 patients (median age: 4 years, range: 1 month - 17 years) with aplastic anemia, acute leukemia and solid tumours prior and after RCT (n=60). Patients received a median of 2 transfusions (range: 1-14). Samples were also collected from the transfusion blood bags and Se concentration was determined quantitatively by atomic absorption spectrometry.
Results:
95% of the specimen collected from the transfusion bags exhibited selenium concentrations within the normal adult range. Mean Se concentration in the patients' blood prior to RCT was 66.2 microg/l (range: 38.0-166.4 microg/l) and increased to 70.7 microg/l (range: 14.1-105.1 microg/l) thereafter (statistically not significant). Applying age dependant reference values Se concentrations were below the lower limit in 45% of the samples prior to RCT and only in 26% after RCT. The reason for this increase was the fact that Se concentrations were often just marginally below the age-dependant lower limit prior to RCT and in the lower normal range thereafter.
Conclusion:
43% of the patients with hemato-oncological diseases in this study exhibited no Se deficiency at any time point. In the remaining 57% of the patients a transient or persistent Se deficiency was detected with blood levels partially far below the lower threshold of the age adjusted normal range. The Se deficiency was corrected in four out of eight patients by RCT. As Se levels may fluctuate in individual pts a supplementation should only be initiated if based on regular monitoring of the Se concentration.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...